1/74
A comprehensive set of vocabulary flashcards covering key terms, drugs, mechanisms, indications, contraindications, adverse effects, and nursing considerations related to CNS stimulants and associated therapies.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Central Nervous System (CNS)
Brain and spinal cord; target or source of most stimulant drug actions and adverse effects.
Excitatory Neurotransmitter
Chemical (e.g., dopamine, norepinephrine, serotonin) that increases neuronal activity in the CNS.
Dopaminergic Drug
Medication that stimulates dopamine receptors to raise CNS activity (e.g., amphetamines).
Adrenergic Drug
Agent that stimulates norepinephrine receptors, producing sympathomimetic CNS effects.
Serotonergic Drug
Drug that acts on serotonin receptors; includes migraine medicines called triptans.
Sympathomimetic Drug
Substance that mimics sympathetic nervous system activity; many CNS stimulants belong here.
CNS Stimulant
Drug that increases neuronal activity in selected brain/spinal cord areas, improving alertness or respiration.
Amphetamine (Class)
Powerful CNS stimulants that elevate mood, alertness, and wakefulness; treat ADHD and narcolepsy.
Xanthine (Class)
Naturally occurring stimulants (e.g., caffeine, theophylline) that enhance respiration via phosphodiesterase inhibition.
Attention-Deficit/Hyperactivity Disorder (ADHD)
Common childhood psychiatric disorder marked by inattention, hyperactivity, and impulsivity.
Narcolepsy
Incurable neurologic disorder characterized by unexpected "sleep attacks" during daytime activities.
Cataplexy
Sudden skeletal-muscle weakness often accompanying narcolepsy episodes.
Obesity
Medical condition defined by BMI ≥ 30 and associated with multiple health risks.
Body Mass Index (BMI)
Weight-for-height index; 25–29.9 = overweight, ≥ 30 = obese.
Migraine
Recurring unilateral or bilateral pulsating headache lasting 4–72 h with nausea, photophobia, & phonophobia.
Photophobia
Sensitivity or avoidance of light, commonly accompanying migraines.
Phonophobia
Sensitivity or avoidance of sound, often present during migraine attacks.
Analeptic
Drug that stimulates CNS areas controlling respiration; used for neonatal apnea or post-anesthetic depression.
Theophylline
Methylxanthine analeptic used to stimulate breathing in neonatal apnea and COPD.
Aminophylline
IV pro-drug of theophylline providing respiratory stimulation.
Caffeine (Pharmacologic)
Methylxanthine CNS stimulant found in beverages, OTC NoDoz, and prescription combos (Fioricet/Fiorinal).
Doxapram (Dopram)
IV analeptic for respiratory depression or COPD hypercapnia; requires reflex monitoring.
Methylphenidate (Ritalin)
First-line stimulant for ADHD and narcolepsy; available in multiple extended-release forms.
Modafinil (Provigil)
Schedule IV non-amphetamine that promotes wakefulness in narcolepsy and shift-work sleep disorder.
Armodafinil (Nuvigil)
R-enantiomer of modafinil with similar wake-promoting effects and low abuse potential.
Atomoxetine (Strattera)
Non-stimulant norepinephrine reuptake inhibitor for ADHD; carries warning for suicidal thoughts in adolescents.
Lisdexamfetamine (Vyvanse)
Pro-drug converted to dextroamphetamine; treats ADHD with lower abuse risk.
Mechanism of Amphetamines
Increase synaptic dopamine & norepinephrine, elevating mood, alertness, and capacity for work.
Respiratory Effects (Amphetamines)
Bronchodilation, increased respiratory rate, and pulmonary artery dilation.
Recent MAOI Usage
Contraindication to stimulants due to risk of hypertensive crisis.
Amphetamine Adverse Effects
Palpitations, tachycardia, hypertension, insomnia, anxiety, nausea, diarrhea, dry mouth, urinary frequency.
Phentermine (Ionamin)
Sympathomimetic anorexiant structurally related to amphetamines but with lower abuse potential.
Benzphetamine (Regimex)
Prescription anorexiant approved for short-term obesity management.
Methamphetamine (Desoxyn)
Controlled anorexiant/stimulant reserved for refractory obesity; high abuse potential.
Diethylpropion (Tenuate)
Appetite-suppressant anorexiant approved for weight loss therapy.
Anorexiant Mechanism
Suppress hypothalamic appetite center, increase basal metabolic rate, mobilize fat, and reduce fat absorption.
Orlistat (Xenical)
Non-stimulant obesity drug that inhibits intestinal lipase, preventing ~30 % of dietary fat absorption.
Qsymia
Combination of phentermine and topiramate used to aid chronic weight management.
Contrave ER
Extended-release naltrexone and bupropion formulation for weight loss.
Saxenda (Liraglutide)
GLP-1 agonist injectable for obesity; marketed as Victoza for type 2 diabetes.
Triptan
Selective serotonin (5-HT1) receptor agonist that aborts acute migraine by cranial vasoconstriction.
Sumatriptan (Imitrex)
Prototype triptan available PO, SC, and nasal spray for rapid migraine relief.
Ergot Alkaloid
Older migraine therapy that constricts cerebral vessels; includes ergotamine and D.H.E. 45.
Dihydroergotamine Mesylate
Injectable or nasal ergot alkaloid (Migranal) for acute migraine treatment.
Ergotamine Tartrate with Caffeine (Cafergot)
Tablet combining ergotamine and caffeine to treat migraines.
Calcitonin Gene-Related Peptide (CGRP) Inhibitor
Injectable or oral monoclonal antibody/antagonist class for migraine prevention or acute treatment.
Onabotulinumtoxin A (Botox)
Injected every 12 weeks for chronic migraine; BBW for systemic toxin spread.
Triptan Adverse Effects
Tingling, flushing, injection-site irritation, and potential dangerous hypertension.
Ergot Adverse Effects
Nausea, vomiting, cold extremities, muscle pain, dizziness.
Analeptic Mechanism (Methylxanthines)
Phosphodiesterase inhibition → ↑ cAMP → CNS respiratory stimulation.
Caffeine Contraindications
Use cautiously with peptic ulcer, recent MI, or dysrhythmias due to stimulant effects.
Doxapram Indication
Respiratory depression from anesthesia, drug overdose, or COPD with hypercapnia.
Drug Holiday
Planned break from stimulant therapy to reduce tolerance and assess ongoing ADHD need.
ADHD Dosing Timing
Give last stimulant dose 4–6 h before bedtime; take 30–45 min before meals on empty stomach.
Anorexiant Caffeine Avoidance
Patients must eliminate caffeine to reduce additive stimulant effects and insomnia.
Vitamin Supplementation with Orlistat
Fat-soluble vitamins (A, D, E, K) may be needed because drug blocks fat absorption.
Serotonin Receptor Agonist Forms
Available as dissolvable wafers, nasal sprays, and self-injectables for migraine self-management.
Amphetamine Examples
Dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate, amphetamine aspartate (Adderall).
Atomoxetine Black Box Warning
Risk of suicidal ideation in pediatric/adolescent ADHD patients; requires close monitoring.
Schedule IV Drug
Federal classification for modafinil/armodafinil due to low but present abuse potential.
Analeptic Vagal Effects
May increase gastric secretions, cause diarrhea, and reflex tachycardia.
Anorexiant Indications
Adjunct to diet & exercise for weight loss, typically restricted to higher-risk obese patients.
Hypertension Risk with Triptans
Serotonin agonists can significantly raise BP; contraindicated in uncontrolled hypertension.
Lipase
Intestinal enzyme inhibited by Orlistat to block dietary fat breakdown and absorption.
Basal Metabolic Rate (BMR)
Energy expenditure at rest; anorexiants increase it to aid weight loss.
Cyclic Adenosine Monophosphate (cAMP)
Intracellular messenger elevated by methylxanthines, leading to respiratory stimulation.
Phosphodiesterase Inhibition
Mechanism whereby xanthines prevent cAMP breakdown, boosting CNS activity.
5-HT1 Receptor
Serotonin receptor subtype stimulated by triptans to constrict cerebral vessels.
Abortive Migraine Therapy
Treatment given during migraine aura/onset to stop headache progression (e.g., triptans).
Vasoconstriction (Triptans)
Narrowing of cerebral arteries that relieves migraine pain but may raise blood pressure.
Botox Black Box Warning
Potential spread of botulinum toxin beyond injection site causing swallowing or breathing problems.
Self-Injectable Triptan
Sumatriptan SC formulation allowing patients rapid at-home migraine relief.
Neonatal Apnea
Breathing pauses in premature infants; often treated with caffeine or theophylline.
COPD-Induced Hypercapnia
Elevated CO₂ in COPD patients; doxapram may stimulate ventilation.
Sympathomimetic Anorexiant
Appetite suppressant that activates adrenergic pathways (e.g., phentermine).